US Stock MarketDetailed Quotes

EIGRQ Eiger BioPharmaceuticals

Watchlist
  • 8.500
  • 0.0000.00%
15min DelayClose Sep 27 16:00 ET
12.59MMarket Cap-0.72P/E (TTM)

Eiger BioPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-109.41%-436.76K
16.98%15.77M
41.06%3.8M
-20.25%3.21M
13.49%4.64M
54.06%4.12M
11.05%13.48M
-19.76%2.7M
32.41%4.02M
95.09%4.09M
Operating revenue
-109.94%-436.76K
21.90%15.52M
41.06%3.8M
-20.25%3.21M
31.49%4.39M
54.06%4.12M
4.88%12.73M
-19.76%2.7M
32.41%4.02M
59.32%3.34M
Cost of revenue
119.27%59.73K
-98.69%24K
-70.72%101K
-90.66%115K
-305.30%-310K
7.27%118K
146.58%1.84M
231.73%345K
287.11%1.23M
-44.07%151K
Gross profit
-110.02%-496.49K
35.22%15.75M
57.46%3.7M
10.78%3.09M
25.71%4.95M
56.07%4M
2.19%11.65M
-27.79%2.35M
2.65%2.79M
115.65%3.94M
Operating expense
-80.14%4.95M
-16.14%87.54M
-39.17%16.32M
-31.34%20.02M
3.81%24.93M
7.71%26.26M
18.17%104.39M
10.97%26.82M
18.68%29.16M
18.98%24.02M
Selling and administrative expenses
-95.22%264.48K
-13.40%25.2M
-43.36%4.7M
-21.68%5.45M
-21.26%5.53M
39.66%9.52M
21.78%29.11M
38.72%8.3M
7.70%6.96M
19.38%7.03M
-General and administrative expense
--264.48K
----
----
----
----
----
----
----
----
----
Research and development costs
----
-17.20%62.33M
-37.29%11.61M
-34.37%14.57M
14.17%19.4M
-4.68%16.75M
16.83%75.28M
1.84%18.52M
22.60%22.2M
18.82%16.99M
Other operating expenses
--4.69M
----
----
----
----
----
----
----
----
----
Operating profit
72.73%-5.45M
22.59%-71.79M
48.45%-12.61M
35.80%-16.93M
0.49%-19.98M
-2.03%-22.26M
-20.54%-92.74M
-17.01%-24.47M
-20.68%-26.37M
-9.36%-20.08M
Net non-operating interest income expense
-6.82%-3.26M
-43.01%-1.07M
-24.43%-927K
4.21%-683K
31.75%-574K
10.32%-3.05M
12.78%-751K
13.27%-745K
15.82%-713K
Non-operating interest income
----
104.07%2.21M
-24.95%352K
39.77%485K
198.64%660K
1,480.00%711K
584.81%1.08M
1,102.56%469K
891.43%347K
569.70%221K
Non-operating interest expense
----
32.28%5.47M
16.89%1.43M
29.30%1.41M
43.79%1.34M
45.03%1.29M
16.10%4.13M
35.56%1.22M
22.15%1.09M
6.14%934K
Other net income (expense)
-5,359.41%-1.58M
109.03%87K
191.36%236K
-5,933.33%-175K
97.30%-29K
103.70%55K
-102.07%-963K
224.00%81K
-99.40%3K
-2,486.67%-1.07M
Special income (charges)
---1.63M
----
----
----
----
----
----
----
----
----
-Less：Restructuring and merger&acquisition
--1.63M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
275.98%51.03K
109.03%87K
191.36%236K
-5,933.33%-175K
97.30%-29K
103.70%55K
-102.07%-963K
224.00%81K
-99.40%3K
-2,486.67%-1.07M
Income before tax
66.02%-7.03M
22.53%-74.96M
46.49%-13.45M
33.50%-18.03M
5.37%-20.69M
-0.65%-22.78M
-185.80%-96.75M
-15.59%-25.14M
-22.08%-27.11M
-14.11%-21.87M
Income tax
-73.91%6K
166.67%2K
0
-88.24%2K
-77.78%2K
-64.06%23K
-116.67%-3K
0
54.55%17K
Net income
66.02%-7.03M
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
Net income continuous Operations
66.02%-7.03M
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
Minority interest income
Net income attributable to the parent company
66.02%-7.03M
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
66.02%-7.03M
22.54%-74.96M
46.48%-13.45M
33.50%-18.03M
5.43%-20.7M
-0.62%-22.78M
-185.33%-96.78M
-15.48%-25.14M
-22.00%-27.11M
-14.13%-21.88M
Basic earnings per share
66.32%-4.7484
27.19%-50.78
46.90%-9.08
33.87%-12.3
7.84%-14.1
18.75%-15.6
-132.47%-69.74
10.94%-17.1
4.62%-18.6
10.53%-15.3
Diluted earnings per share
66.32%-4.7484
27.19%-50.78
46.90%-9.08
33.87%-12.3
7.84%-14.1
18.75%-15.6
-132.47%-69.74
10.94%-17.1
4.62%-18.6
10.53%-15.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -109.41%-436.76K16.98%15.77M41.06%3.8M-20.25%3.21M13.49%4.64M54.06%4.12M11.05%13.48M-19.76%2.7M32.41%4.02M95.09%4.09M
Operating revenue -109.94%-436.76K21.90%15.52M41.06%3.8M-20.25%3.21M31.49%4.39M54.06%4.12M4.88%12.73M-19.76%2.7M32.41%4.02M59.32%3.34M
Cost of revenue 119.27%59.73K-98.69%24K-70.72%101K-90.66%115K-305.30%-310K7.27%118K146.58%1.84M231.73%345K287.11%1.23M-44.07%151K
Gross profit -110.02%-496.49K35.22%15.75M57.46%3.7M10.78%3.09M25.71%4.95M56.07%4M2.19%11.65M-27.79%2.35M2.65%2.79M115.65%3.94M
Operating expense -80.14%4.95M-16.14%87.54M-39.17%16.32M-31.34%20.02M3.81%24.93M7.71%26.26M18.17%104.39M10.97%26.82M18.68%29.16M18.98%24.02M
Selling and administrative expenses -95.22%264.48K-13.40%25.2M-43.36%4.7M-21.68%5.45M-21.26%5.53M39.66%9.52M21.78%29.11M38.72%8.3M7.70%6.96M19.38%7.03M
-General and administrative expense --264.48K------------------------------------
Research and development costs -----17.20%62.33M-37.29%11.61M-34.37%14.57M14.17%19.4M-4.68%16.75M16.83%75.28M1.84%18.52M22.60%22.2M18.82%16.99M
Other operating expenses --4.69M------------------------------------
Operating profit 72.73%-5.45M22.59%-71.79M48.45%-12.61M35.80%-16.93M0.49%-19.98M-2.03%-22.26M-20.54%-92.74M-17.01%-24.47M-20.68%-26.37M-9.36%-20.08M
Net non-operating interest income expense -6.82%-3.26M-43.01%-1.07M-24.43%-927K4.21%-683K31.75%-574K10.32%-3.05M12.78%-751K13.27%-745K15.82%-713K
Non-operating interest income ----104.07%2.21M-24.95%352K39.77%485K198.64%660K1,480.00%711K584.81%1.08M1,102.56%469K891.43%347K569.70%221K
Non-operating interest expense ----32.28%5.47M16.89%1.43M29.30%1.41M43.79%1.34M45.03%1.29M16.10%4.13M35.56%1.22M22.15%1.09M6.14%934K
Other net income (expense) -5,359.41%-1.58M109.03%87K191.36%236K-5,933.33%-175K97.30%-29K103.70%55K-102.07%-963K224.00%81K-99.40%3K-2,486.67%-1.07M
Special income (charges) ---1.63M------------------------------------
-Less：Restructuring and merger&acquisition --1.63M------------------------------------
Other non- operating income (expenses) 275.98%51.03K109.03%87K191.36%236K-5,933.33%-175K97.30%-29K103.70%55K-102.07%-963K224.00%81K-99.40%3K-2,486.67%-1.07M
Income before tax 66.02%-7.03M22.53%-74.96M46.49%-13.45M33.50%-18.03M5.37%-20.69M-0.65%-22.78M-185.80%-96.75M-15.59%-25.14M-22.08%-27.11M-14.11%-21.87M
Income tax -73.91%6K166.67%2K0-88.24%2K-77.78%2K-64.06%23K-116.67%-3K054.55%17K
Net income 66.02%-7.03M22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M
Net income continuous Operations 66.02%-7.03M22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M
Minority interest income
Net income attributable to the parent company 66.02%-7.03M22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 66.02%-7.03M22.54%-74.96M46.48%-13.45M33.50%-18.03M5.43%-20.7M-0.62%-22.78M-185.33%-96.78M-15.48%-25.14M-22.00%-27.11M-14.13%-21.88M
Basic earnings per share 66.32%-4.748427.19%-50.7846.90%-9.0833.87%-12.37.84%-14.118.75%-15.6-132.47%-69.7410.94%-17.14.62%-18.610.53%-15.3
Diluted earnings per share 66.32%-4.748427.19%-50.7846.90%-9.0833.87%-12.37.84%-14.118.75%-15.6-132.47%-69.7410.94%-17.14.62%-18.610.53%-15.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!